Lisa Baker
Family · Atwater, CANPI 1205489903
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $734 and has fallen 94.9% since, to $37 in 2025.
Across 64 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$203
- Novo Nordisk$168
- Merck$96
- Mayne Pharma Commercial LLC$78
- Sanofi-aventis U.S. LLC$62
- Avanir Pharmaceuticals, Inc.$61
- plus $423 from 16 others
What the payments were for
- Food & beverage$1,092100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $203 |
| Novo Nordisk | 9 | $168 |
| Merck | 5 | $96 |
| Mayne Pharma Commercial LLC | 11 | $78 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| Avanir Pharmaceuticals, Inc. | 3 | $61 |
| GSK | 2 | $42 |
| Boehringer Ingelheim | 2 | $38 |
| Radius Health, Inc. | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Sun Pharmaceutical Industries Inc. | 2 | $34 |
| Astellas Pharma US Inc | 2 | $31 |
| AbbVie | 2 | $30 |
| Exact Sciences | 1 | $25 |
| Urovant Sciences Inc | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Bayer | 1 | $17 |
| Adamas Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$1,092 in reported general payments places this provider in the 75th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $32,762 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $2,412 |
| Metoprolol Succinate | 58 | $1,356 |
| Ventolin HfaAlbuterol Sulfate | 11 | $1,269 |
| Levothyroxine Sodium | 103 | $1,159 |
| Gabapentin | 35 | $851 |
| Tamsulosin Hcl | 35 | $629 |
| Atorvastatin Calcium | 78 | $603 |
| Losartan Potassium | 51 | $540 |
| Lisinopril | 58 | $438 |
| Omeprazole | 54 | $428 |
| Rosuvastatin Calcium | 29 | $380 |
| Potassium Chloride | 18 | $358 |
| Atenolol | 12 | $311 |
| Amlodipine Besylate | 63 | $300 |
Paid to pharmacies, not to this prescriber.
Other family in Atwater
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.